CHATHAM SKIN AND CANCER CENTER, PC 639A Stephenson Ave Savannah

合集下载

美国MD安德森癌症中心就医指南篇

美国MD安德森癌症中心就医指南篇

MD 安德森就医指南:治疗技术篇1、神经肿瘤遗传缺陷研究 神经肿瘤中心还对遗传缺陷进行专门研究。

神经纤维瘤病是一种驱动神经系统肿瘤生长的遗 传缺陷。

来自神经肿瘤中心、 神经外科中心和实验癌症治疗中心的专家组成了一个神经纤维瘤病工作组, 该工作组不仅为神经纤维瘤病患者提供特殊护理和治疗, 还通过转化研究为这些患者寻找更出色的治疗方法。

2、积极寻找胃肠癌症更准确的诊断和筛查手段为患者提供先进的治疗方法和参与临床试验的机会是胃肠肿瘤中心的使命, 提高胃肠癌症患 者的生存率和生活质量是中心的目标。

MD 安德森癌症研究中心专家正在努力寻找更好的治疗方法以及可以尽早检测出胃肠癌症的更准确的诊断和筛查手段。

3、为患者施细胞减压术妇产肿瘤中心可治疗所有类型的妇科癌症, 包括卵巢癌、 恶性卵巢生 间质肿瘤、 卵巢交界性肿瘤、 阴道癌、 外阴癌、子宫内膜癌、 宫颈癌、 殖细胞肿瘤、 卵巢性索 宫颈上皮内瘤样病变、妊娠滋养细胞疾病等。

妇产肿瘤中心还可以对人类乳头瘤病毒感染患者进行治疗, 为患者实 施细胞减压术。

4、世界最大的质子治疗中心 安德森癌症质子治疗中心依靠正电子发射断层成像( PET )、电脑模拟和核磁共振影像方面 的先进技术, 结合质子治疗, 在肺癌早期诊断方面已经取得了明显进展。

质子治疗对前列腺 癌、肺癌、部分儿童肿瘤、头颈部癌症及眼部肿瘤都有很明显的治疗效果。

5、其它先进医疗技术 泌尿中心的医师在冷冻手术、腹腔镜检查术和机器人手术等微创手术领域具有丰富的经验。

MD 安德森就医指南:费用篇 去美国看病的费用主要包括医疗费和生活费。

很多朋友想了解国外看病的具体医疗费用, 但是医疗费用因个体因素差异很大, 所以很难预 估。

由于医疗费用因为个体因素差距很大, 同一所医院相同的疾病也可能治疗费用相差数倍, 所以此价格单只是给大家一个参考, 具体治疗费用还是以医院评估为准。

医疗费用分为两 部分,一部分是医生、护士及护工等的看诊、护理等人工费用,一部分是检查、药物治疗、 放射治疗等费用。

PD-1抑制剂致肌炎伴重症肌无力1例分析

PD-1抑制剂致肌炎伴重症肌无力1例分析

PD-1抑制剂致肌炎伴重症肌无力1例分析郭凯*朱斌汪丰**(复旦大学附属肿瘤医院药剂科、复旦大学上海医学院肿瘤学系上海 200032)摘要 PD-1抑制剂的广泛临床使用在改善肿瘤治疗效果的同时,其日渐增多的严重免疫相关不良反应也值得关注。

本文对1例国产PD-1抑制剂(信迪利单抗)在肺癌患者治疗两周期后出现全身酸痛,伴胸闷、气促的案例进行了讨论分析。

该患者考虑为PD-1抑制剂治疗后引起免疫相关性肌炎累及心肌、横纹肌溶解伴重症肌无力的重叠综合征。

予以激素冲击联合免疫球蛋白抗炎治疗、溴吡斯的明对症治疗,期间行血浆置换治疗,患者治疗结果好转。

因此,及时、足量的糖皮质激素,联合免疫球蛋白以及溴吡斯的明可以用于PD-1抑制剂引起的免疫相关性多发肌炎伴重症肌无力的治疗。

关键词 PD-1抑制剂肌炎/心肌炎重症肌无力信迪利单抗不良反应中图分类号:R979.19; R969.3 文献标志码:C 文章编号:1006-1533(2020)03-0056-04A case report of myositis and myasthenia gravis induced by PD-1 inhibitors treatmentGUO Kai*, ZHU Bin, WANG Feng**(Department of Pharmacy, Shanghai Cancer Center, Fudan University; Department of Oncology,Shanghai Medical College, Fudan University, Shanghai 200032, China)ABSTRACT The clinical widespread use of PD-1 inhibitors not only improves the therapeutic effect of tumors, but also its increasing number of serious immune-related adverse reactions is also worthy of attention. Some severe, potentially life-threatening adverse reactions such as systemic soreness with chest tightness, shortness of breath and discomfort and ECG changes, rise of creatine kinase and myocardial markers occurred in a non-small cell lung cancer treated with home-made sintilimab for two treatment courses were analyzed. This patient was considered to be immune-related myositis involving myocardium and rhabdomyolysis with myasthenia gravis (MG) overlap syndrome caused by PD-1 inhibitor treatment and was treated with steroid, immunoglobulin and symptomatic treatment of pyridostigmine and meanwhile plasma exchange was performed. The patient’s condition was improved after treatment. Therefore, the occurrence of severe immune-related adverse reactions should be alerted when PD-1 inhibitors need to be used. Timely and sufficient glucocorticoids combined with immunoglobulins and pyridostigmine should be used for the treatment of immune-related polymyositis with myasthenia gravis caused by PD-1 inhibitor therapy.KEY WORDS PD-1 inhibitors; myositis/myocarditis; myasthenia gravis; sintilimab; adverse events近年来,免疫检查点抑制剂(immune checkpoint inhibitors, ICIs)的临床应用显示出了巨大的优势和发展潜力,对于肿瘤免疫治疗具有重大意义。

NCCN临床实践指南:外阴癌(鳞状细胞癌)(2020.V2

NCCN临床实践指南:外阴癌(鳞状细胞癌)(2020.V2
Continue
Amanda Nickles Fader, MD Ω The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Steven W. Remmenga, MD Ω Fred & Pamela Buffett Cancer Center
NCCN Guidelines Version 2.2020 Vulvar Cancer (Squamous Cell Carcinoma)
NCCN Guidelines Index Table of Contents Discussion
NCCN Vulvar Cancer Panel Members Summary of the Guidelines Updates
Emily Wyse ¥ Patient Advocate NCCN Nicole McMillian, MS Angela Motter, PhD
Ω Gynecologic oncology Þ Internal medicine † Medical oncology ≠ Pathology ¥ Patient advocacy § Radiotherapy/Radiation oncology * Discussion Section Writing Committee
Printed by Qiu Shida on 6/24/2020 10:07:28 AM. For personal use only. Not approved for distribution. Copyright © 2020 National Comprehensive Cancer Network, Inc., All Rights Reserved.

40种肿瘤类SCI杂志_影响因子IF小于5_特点

40种肿瘤类SCI杂志_影响因子IF小于5_特点

美国国立癌症研究所(NCI)、疾病控制与预防中心(CDC)、美国癌症学会(ACS)、北美肿瘤登记中心联合会(NAACCR)四大权威机构联合发布的这项报告指出由中国抗癌协会主办、目前在肿瘤学院的英文杂志《Chinese Journal of Cancer Research》(中国癌症研究)被SCI和JCR正式收录。

英文杂志《Chinese Journal of Cancer Research》已于2013年1月被PubMed正式收录,该杂志于2008年已被SCI(科学引文索引)收录。

这是国内唯一一家肿瘤学英文杂志(《Chinese Journal of Cancer Research》)同时被PubMed和SCI收录4-5分多的International journal of cancer, or European journal of cancer,or Cancer.IF=7-8的肿瘤类期刊,只有Oncogene 和Cancer Research,而Cancer Research在字数和图表数以及Western结果等方面有相当近乎苛刻的要求。

杂志名称:Journal of cancer research and clinical oncology专业领域:肿瘤学杂志国家:德国影响因子:2010 ;2009 ;2008 看来影响因子在涨但涨幅不大投稿日期:2011-6-8?投稿方式:在线投稿?修改方式:minor revision 2011-7-13接受日期:2011-7-13?在线出版:2011-7-26印刷出版:2011-8是否收版面费:无版面费包括彩图个人评价:1.效率高,如果据稿1周之内编辑不送外审直接给答复不耽误改投它刊;如果接受会转交Springer 从校稿到在线出版再到印刷出版时间不会太长;所以如果毕业或晋升急用,比较适合不耽误工夫2.比较友好:浏览了该杂志的文章好多都是中国人发表的所以不会对中国有歧视3. 比较好中,主要偏临床或临床与基础结合的文章如临床病例分析临床病理组织学研究等;关键是创新性要有这一点是关键。

嗅觉的机制

嗅觉的机制
2004年诺贝尔生理学或医学奖
2004年10月4日,诺贝尔基金会宣布把 本年度的诺贝尔生理学或医学奖颁发给 美国科学家Richard Axel理查德· 阿克塞 尔和Linda B. Buck琳达· 巴克,以表彰 他们在研究人类嗅觉方面的贡献。 两位科学家的主要成就在于他们揭示 了人类嗅觉系统的奥秘,告诉世界“我 们是如何能够辨认和记得1万种左右的 气味”的。
Axel和Buck的答案
阿克塞尔、巴克和他的同事们开始研究嗅 觉神经细胞的蛋白质受体,但是他们并没有直 接研究蛋白质,而是转而研究基因。基因是组 成我们身体的蛋白质的“图纸”。通常一个基 因负责制造一种蛋白质。既然在嗅觉神经细胞 的细胞膜上有蛋白质,那么就一定有对应的基 因。通过基因克隆的方法。阿克塞尔找到了一 群负责制造蛋白质受体的基因。这一群基因只 在嗅觉神经细胞中表达。
阿克塞尔和巴克所发现的嗅觉系统的一 般性原理似乎也可以应用到其他感觉系统。 比如另外一种用于传递信息的“气味”— —信息素(pheromones)。 昆虫常常使用这类物质。在哺乳动物中 也有类似的现象,但是即便哺乳动物也使 用类似的信息素,它们也不是由嗅觉上皮 负责感知的。在鼻腔中有一个叫做犁鼻器 (vomeronasal organ)的组织负责感知信息素。
The Nobel Prize in Physiology or Medicine 2004
Richard Axel 1/2 of the prize USA
Linda B. Buck 1/2 of the prize USA Fred Hutchinson Cancer Research Center Seattle, WA, USA
对于嗅觉产生机理这一难解的迷题, 终 于由2004年度诺贝尔生理学或医学奖获奖者、 美国科学家理查德· 阿克塞尔和琳达· 巴克, 通过他们自己开拓性的工作找到了解开这一 谜底的钥匙。两位科学家于1991年发表了有 关这一课题的基础论文,介绍了气味受体基 因大家族。后来,两人又各自独立工作,更 加深入地阐明了整个嗅觉系统的工作原理。

2012年NCCN宫颈癌指南

2012年NCCN宫颈癌指南

Continue
Version 1.2012, 08/11/11 © National Comprehensive Cancer Network, Inc. 2011, All rights reserved. The NCCN Guidelines™ and this illustration may not be reproduced in any form without the express written permission of NCCN®.
NCCN Guidelines Index Cervical Cancer TOC Discussion
Clinical Trials: The NCCN believes that the best management for any cancer patient is in a clinical trial. Paecially encouraged. To find clinical trials online at NCCN member institutions, click here: /clinical_trials/physician.html
NCCN Lauren Gallagher, RPh, PhD Miranda Hughes, PhD Nicole McMillian, MS NCCN Guidelines Panel Disclosures
Continue
W Gynecologic oncology † Medical oncology ‡ Hematology § Radiotherapy/Radiation oncology ¹ Pathology * Writing committee member

美国十大癌症及肿瘤治疗医院介绍

美国十大癌症及肿瘤治疗医院介绍

根据悦安健康引述美国时代杂志的最新排名数据,美国目前排名前十癌症治疗医院分别为:#1美国MD安德森肿瘤中心- University of Texas M.D. Anderson Cancer Center美国MD安德森癌症中心(University of Texas MD Anderson Cancer Center, UT MDA)位于德克萨斯州休斯顿,始建于1941年,是集肿瘤临床诊断、综合治疗及基础科研于一体的大型专科医院,在全美乃至全球享有盛名,2008年再度被评为全美最佳癌症研究机构(NO1),这也是安德森癌症中心在9年内第6次获得该项殊荣。

MD安德森癌症中心自1951年开始提供神经外科诊疗服务,先后成立神经外科(Neurosurgery),神经肿瘤科(Neuro-Oncology)。

1993年,MD 安德森癌症中心整合神经外科、神经肿瘤科、神经肿瘤病理、神经影像、神经肿瘤放疗、儿童肿瘤、心理学、流行病学及统计的优势,成立神经肿瘤中心,旨在通过多学科的协作,最大限度的提高神经肿瘤患者的预后及生活质量。

MD安德森癌症中心神经肿瘤中心具有雄厚临床科研实力,2006年接诊病人18000例,有31项在研临床试验,另有11项临床试验待启动。

神经肿瘤中心拥有1000余平方米的独立实验研究空间,目前共有12个专科71位临床医生及基础研究人员协作,其中42%的临床医生参与基础科学研究,有多位在神经肿瘤专业相关领域具有较高的学术威望。

神经肿瘤中心2006年发表学术论文171篇,获得联邦基金42项,共计1160万美元;与药厂合作开发新药,获得资助730万美元;获得各类基金会资助160万美元。

神经外科:如前所述,MD安德森癌症中心自1951年提供神经外科诊疗服务。

1979年,于头颈外科下设神经外科分区。

1990年,MD安德森癌症中心正式成立独立的神经外科,由Raymond Sawaya教授担任科室负责人至今。

分析性临床医学研究:队列研究的设计要点

分析性临床医学研究:队列研究的设计要点

·临床研究规范·分析性临床医学研究:队列研究的设计要点王瑞平1肇晖2吴颖2李斌1(1. 上海市皮肤病医院临床研究与创新转化中心上海 200443;2. 上海医药行业协会上海 200003)摘要队列研究是分析性流行病学一种重要研究类型,其本质上属于观察法。

队列研究中,研究者不能根据自己的设想对研究进行处理或干预。

通常,应根据研究对象目前或过去某个时期是否暴露于研究的因素或不同的暴露水平将研究对象分为不同组别,如暴露组和非暴露组,高剂量暴露组和低剂量组,再通过采集相关信息并随访观察一段时间后,观察登记不同暴露人群的结局事件发生情况,比较各组结局的发生率,从而评估和检验危险因素与结局的关系。

本文从队列研究的基础概念入手,介绍队列研究的分类、样本量估算、队列研究设计的要点及应用等内容,以期为临床医务人员开展队列研究设计提供参考。

关键词队列研究 回顾性 前瞻性 双向性 设计要点中图分类号:R969.4 文献标志码:C 文章编号:1006-1533(2023)23-0030-02引用本文王瑞平, 肇晖, 吴颖, 等. 分析性临床医学研究:队列研究的设计要点[J]. 上海医药, 2023, 44(23): 30-31; 39.Analytic clinical medical research: key points in the design of cohort studiesWANG Ruiping1, ZHAO Hui2, WU Ying2, LI Bin1(1. Clinical Research & Innovation Center, Shanghai Skin Disease Hospital, Shanghai 200443, China;2. Shanghai Pharmaceutical Profession Association, Shanghai 200003, China)ABSTRACT Cohort study is an important type of study in analytical epidemiology, which is essentially observational in nature. In a cohort study, the researcher cannot treat or intervene in the study as his or her envisions. Usually, the study subjects should be divided into different groups according to whether they are currently or at some time in the past exposed to the factors under study or different levels of exposure, such as exposed and non-exposed groups, high-dose exposure groups and low-dose groups, and then, by collecting relevant information and following up and observing for a period of time, observe and register the occurrence of the outcome events in the different exposed populations, and compare the rates of the outcomes in each group, so as to evaluate and test the relationship between risk factors and outcomes. This article starts from the basic concepts of cohort study and introduces the classification of cohort study, sample size estimation, key points of cohort study design and its application so as to provide reference for clinical medical personnel working on the design of cohort study.KEY WORDS cohort study; retrospective; prospective; bidirectional; design points流行病学(epidemiology)作为一门基础学科,是研究人群中疾病与健康状况分布及其影响因素,并研究防治疾病及促进健康的策略和措施的科学[1]。

2011 NCCN Thymomas and Thymic Carcinomas

2011 NCCN Thymomas and Thymic Carcinomas
NCCN Categories of Evidence and
Consensus: All recommendations are Category 2A unless otherwise specified. See NCCN Categories of Evidence and Consensus
Printed by sky script on 6/10/2011 11:11:30 PM. For personal use only. Not approved for distribution. Copyright © 2011 National Comprehensive Cancer Network, Inc., All Rights Reserved.
Thymomas and Thymic Carcinomas
Version 2.2011
Continue
Version 2.2011, 03/24/11 © National Comprehensive Cancights reserved. The NCCN Guidelines™ and this illustration may not be reproduced in any form without the express written permission of NCCN®.
Printed by sky script on 6/10/2011 11:11:30 PM. For personal use only. Not approved for distribution. Copyright © 2011 National Comprehensive Cancer Network, Inc., All Rights Reserved.

美国十大癌症医院公布(附最省钱看病攻略)

美国十大癌症医院公布(附最省钱看病攻略)

美国十大癌症医院公布(附最省钱看病攻略)7月30日,《美国新闻与世界报道》(U.S. News & World Report),发布了2019年-2020年度美国最佳癌症专科医院排名,10家上榜医院中, 位于休斯敦市的MD安德森癌症中心保留了其作为该国第一大癌症医院的地位。

这是MD Anderson连续第5年- 也是18年来的第15次排名第一。

自该出版物于1990年开始发布以来,这家癌症中心每年在癌症护理方面均占据了这个排行榜的第一或第二。

安德森癌症中心是世界公认的权威肿瘤专科医院,这家规模庞大的医疗中心,以其强大的医疗水准以及新药试验,吸引着每年来自世界各地的近13万名患者来这里就诊。

这些上榜医院代表了美国、乃至全世界当下前沿的医疗水平。

在发布本榜单的同时,特别提供每个医院自行就医的相关贴士:中国癌症病人如果选择赴美治疗,除了选择中介这一需要更多的费用外,最便捷省钱的办法,就是与这上面的十家癌症医院的任一一家医院直接联系。

这十家医院原则上都特设有国际部,为来自世界各地的国际病人提供免费语言与转诊服务。

其中就包括中文服务。

最重要的是,这一切都是免费的。

第一名:MD安德森癌症中心(University of Texas MD Anderson Cancer Center)休斯顿的德克萨斯大学MD安德森癌症中心是美国三个最初的综合癌症中心之一。

MD安德森癌症中心被广泛认为是世界上最重要的癌症医院之一。

这家教学医院拥有近20,000员工,近2000名来自世界各地的精英医生,每年收治美国和其他国家的住院患者超过135,000人,其中不乏各国政要和商业精英。

这家癌症中心在肺癌、前列腺癌、卵巢癌、头颈癌、肠癌、胰腺癌、黑色素瘤、罕见癌症等多个领域处于全球领先地位。

在安德森治疗肿瘤,还有一个全球性的优势,能先于世界上其他病人数年的时间用上最新的肿瘤药物,因为这里是世界上最大的肿瘤药物临床试验基地,大多数的肿瘤药物都是从安德森的临床试验出来后上市的。

pancreatic

pancreatic
nes in Oncology – v.2.2010
Pancreatic Adenocarcinoma
Guidelines Index Pancreatic Table of Contents Staging, Discussion, References
Table of Contents NCCN Pancreatic Adenocarcinoma Panel Members Summary of Guidelines Updates Clinical Suspicion of Pancreatic Cancer or Evidence of Dilated Pancreatic and/or Bile Duct (PANC-1) No Metastatic Disease on Physical Exam or by Imaging (PANC-2) Resectable, Work-Up, Treatment (PANC-3) Borderline Resectable, No Metastases, Work-Up (PANC-4) Borderline Resectable, No Metastases, No Jaundice, Treatment (PANC-5) Borderline Resectable, No Metastases, Jaundice, Treatment (PANC-6) Post-Operative Adjuvant Treatment (PANC-7) Locally Advanced, Unresectable (PANC-8, PANC-9) Metastatic Disease (PANC-10) Recurrence After Resection (PANC-11) Principles of Diagnosis and Staging (PANC-A) Criteria Defining Resectability Status (PANC-B) Principles of Palliation and Supportive Care (PANC-C) Principles of Radiation Therapy (PANC-D) Principles of Chemotherapy (PANC-E)

姑息治疗指南

姑息治疗指南
NCCN Categories of Evidence and
Consensus: All recommendations are category 2A unless otherwise specified. See NCCN Categories of Evidence and Consensus
Jennifer Temel, MD † £ Massachusetts General Hospital Cancer Center Roma Tickoo, MD, MPH ₪ £ Memorial Sloan-Kettering Cancer Center Susan G. Urba, MD † £ University of Michigan Comprehensive Cancer Center Carin Van Zyl, MD £ City of Hope Comprehensive Cancer Center Jamie H. Von Roenn, MD ‡ Robert H. Lurie Comprehensive Cancer Center of Northwestern University Sharon M. Weinstein, MD £ Y Huntsman Cancer Institute at the University of Utah
NCCN Guidelines Version 1.2013 Panel Members Palliative Care
* Michael H. Levy, MD, PhD/Chair † £ Fox Chase Cancer Center
NCCN Guidelines Index Palliative Care TOC Discussion

癌症中心英语

癌症中心英语

癌症中心英语The Cancer CenterIn the heart of the city lies a beacon of hope for countless patients and their families—the Cancer Center. This state-of-the-art facility is dedicated to the comprehensive care and treatment of individuals affected by cancer. The center is a testament to the advancements in medical science and the unwavering commitment to improving the quality of life for those battling this devastating disease.The Cancer Center boasts a team of highly skilled oncologists, surgeons, radiologists, and other healthcare professionals who work tirelessly to provide the best possible care. They are supported by cutting-edge technology, including advanced imaging equipment and precision surgical tools, which enable them to diagnose and treat cancer with remarkable accuracy.One of the center's key strengths is itsmultidisciplinary approach to treatment. Patients benefit from a collaborative effort between various specialists who work together to develop a personalized treatment plan. This ensures that each patient receives the most effective care tailored to their unique needs and circumstances.The center also places a strong emphasis on research andinnovation. It is actively involved in numerous clinicaltrials and research projects aimed at discovering new treatments and improving existing ones. This commitment to innovation ensures that the Cancer Center remains at the forefront of cancer care.Support services are an integral part of the Cancer Center's mission. Patients and their families have access to a range of support services, including counseling,nutritional guidance, and physical therapy. These services are designed to address the emotional and physical challenges that often accompany a cancer diagnosis.Furthermore, the Cancer Center is committed to educating the public about cancer prevention, early detection, and treatment options. Through community outreach programs and educational seminars, the center plays a vital role inraising awareness and dispelling myths about cancer.In conclusion, the Cancer Center stands as a symbol of hope and healing. Its dedication to providing exceptional care, fostering innovation, and supporting patients and their families has made it a vital resource in the fight against cancer. As we continue to make strides in cancer research and treatment, the Cancer Center will undoubtedly remain a cornerstone in the journey towards a world free from the burden of this disease.。

宫颈癌治疗指南

宫颈癌治疗指南

Guidelines Index Cervical Cancer TOC Staging, MS, References
NCCN Cervical Cancer Panel Members
* Benjamin E. Greer, MD/Co-Chair W Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance * Wui-Jin Koh, MD/Co-Chair § Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance Nadeem R. Abu-Rustum, MD W Memorial Sloan-Kettering Cancer Center Michael A. Bookman, MD † Fox Chase Cancer Center Robert E. Bristow, MD W The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Susana Campos, MD † Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center Kathleen R. Cho, MD ¹ University of Michigan Comprehensive Cancer Center Larry Copeland, MD W Arthur G. James Cancer Hospital & Richard J. Solove Research Institute at The Ohio State University Patricia Eifel, MD § The University of Texas M. D. Anderson Cancer Center Warner K. Huh, MD W University of Alabama at Birmingham Comprehensive Cancer Center Wainwright Jaggernauth, MD § Roswell Park Cancer Institute Daniel S. Kapp, MD, PhD § Stanford Comprehensive Cancer Center John Kavanagh, MD † The University of Texas M. D. Anderson Cancer Center Gary H. Lipscomb, MD W St. Jude Children’s Research Hospital/University of Tennessee John R. Lurain, III, MD W Robert H. Lurie Comprehensive Cancer Center of Northwestern University Mark A. Morgan, MD W Fox Chase Cancer Center Robert J. Morgan, Jr., MD † ‡ City of Hope C. Bethan Powell, MD W UCSF Comprehensive Cancer Center Steven W. Remmenga, MD W UNMC Eppley Cancer Center at The Nebraska Medical Center R. Kevin Reynolds, MD W University of Michigan Comprehensive Cancer Center Angeles Alvarez Secord, MD W Duke Comprehensive Cancer Center * William Small, Jr., MD § Robert H. Lurie Comprehensive Cancer Center of Northwestern University Nelson Teng, MD, PhD W Stanford Comprehensive Cancer Center

NCCN Adult cancer pain

NCCN Adult cancer pain
NCCN Guidelines Index Adult Cancer Pain TOC Discussion
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines )
®
Adult Cancer Pain
Version 2.2013
Continue
Version 2.2013, 05/29/13 © National Comprehensive Cancer Network, Inc. 2013, All rights reserved. The NCCN Guidelines® and this illustration may not be reproduced in any form without the express written permission of NCCN®.
Continue
NCCN Guidelines Panel Disclosures
Version 2.2013, 05/29/13 © Cancer Network, Inc. 2013, All rights reserved. The NCCN Guidelines® and this illustration may not be reproduced in any form without the express written permission of NCCN®.
j Anesthesiology £ Supportive care including palliative, pain management, pastoral care, and oncology social work † Medical oncology Þ Internal medicine q Psychiatry, psychology, including health behavior # Nursing § Radiotherapy/Radiation oncology å Pharmacology Y Neurology/neuro-oncology ¥ Patient advocacy * Writing committee member

2014华氏巨球蛋白血症nccn指南

2014华氏巨球蛋白血症nccn指南
† Medical oncology ‡ Hematology x Bone marrow transplantation ¶ Surgery/Surgical oncology § Radiotherapy/Radiation oncology € Pediatric oncology Þ Internal medicine * Writing committee member
NCCN Guidelines Index WM/LPL Table of Contents Discussion
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines )
®
Waldenstrom’s ¨ Macroglobulinemia / Lymphoplasmacytic Lymphoma
NCCN Guidelines Version 1.2014 Panel Members Waldenstrom’s Macroglobulinemia/ ¨ Lymphoplasmacytic Lymphoma
* Kenneth C. Anderson, MD/Chair ‡ Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center William Bensinger, MD/Vice Chair † x Fred Hutchinson Cancer Research Center/ Seattle Cancer Care Alliance Melissa Alsina, MD ‡ Moffitt Cancer Center J. Sybil Biermann, MD ¶ University of Michigan Comprehensive Cancer Center Jason C. Chandler, MD † St. Jude Children’s Research Hospital/ The University of Tennessee Health Science Center Caitlin Costello, MD ‡ UC San Diego Moores Cancer Center Steven Devine, MD † The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute Benjamin Djulbegovic, MD, PhD † ‡ x Moffitt Cancer Center Cristina Gasparetto, MD † Duke Cancer Institute Francisco Hernandez-Illizaliturri, MD † Roswell Park Cancer Institute Carol Ann Huff, MD † The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Adetola Kassim, MD, MS ‡ x Vanderbilt-Ingram Cancer Center

直肠癌

直肠癌

*Leonard Saltz, MD † ‡ Þ Memorial Sloan-Kettering Cancer Center
Continue
NCCN Guidelines Panel Disclosures
Version 1.2011, 09/10/10 © National Comprehensive Cancer Network, Inc. 2010, All rights reserved. The NCCN Guidelines™ and this illustration may not be reproduced in any form without the express written permission of NCCN®.
NCCN Guidelines™ Version 1.2011 Panel Members Anal Carcinoma
* Paul F. Engstrom, MD/Chair † Fox Chase Cancer Center
J. Pablo Arnoletti, MD ¶ University of Alabama at Birmingham Comprehensive Cancer Center Charles S. Fuchs, MD, MPH † Dana-Farber/Brigham and Women's Cancer Center Jean L. Grem, MD † UNMC Eppley Cancer Center at The Nebraska Medical Center James A. Knol, MD ¶ University of Michigan Comprehensive Cancer Center Lucille A. Leong, MD † City of Hope Comprehensive Cancer Center Edward Lin, MD † Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance Mary F. Mulcahy, MD ‡ Robert H. Lurie Comprehensive Cancer Center of Northwestern University Eric Rohren, MD, PhD ф The University of Texas MD Anderson Cancer Center David P. Ryan, MD † Massachusetts General Hospital Cancer Center

关于新加坡国立大学癌症中心-nationaluniversitycancerinstitute

关于新加坡国立大学癌症中心-nationaluniversitycancerinstitute

****************************.sgThe Na versity Cancer Ins te,Singapore (NCIS) has come a long way since thefirst ambulatory oncology centre was set up in Singapornot have a dedicated centre to receive chemotherapy. Todayrently sited at KentRidge Wdepartments of HaematologyGynaecologic, Surgical, Nursing and PharmacyOncology. It is also the only facility in Singapore that trwithin the same premises.Tr’sat the NUH Medical Centre (NUHMC) come August 2013. Thislandmark building is and NCIS will span across Levels 8, 9and 10.NCIS@ the new NUH Medical CentreDedicated Cancer Care关于新加坡国立大学癌症中心新加坡国立大学医院在1988年9月成立了第一个门诊肿瘤中心。

在此之前,癌症患者并没有一个能接受化疗的治疗中心,而在1988年所成立的门诊肿瘤中心,现在已经扩大与发展成今日的 新加坡国立大学癌症中心并创造了许多辉煌的成绩。

目前位于国大医院肯特岗座的新加坡国立大学癌症中心已拥有出色的专业技能与设施。

它汇集了血液,放射,儿科,妇科,外科,护理与肿瘤药剂等各部门的专业知识与技能。

它也是新加坡唯一一家治疗儿童和成人癌症的综合公共癌症中心。

新加坡国立大学癌症中心的门诊服务将于2013年8月搬迁至国大医院医疗中心,以便提供更完善的癌症护理服务。

英国Maggie Fife第五癌症中心

英国Maggie Fife第五癌症中心

设计风格英式建筑风格英国Maggie's Fife第五癌症中心 Maggie's Fife Cancer Center, UK 设计:Zaha Hadid点击图片进入下一页>>Maggie's Fife第五癌症中心点击图片进入下一页>>Maggie's Fife第五癌症中心设计特色:Zaha Hadid 将 Maggie's Centre Fife 癌症疗养中心巧妙地安置于山谷斜坡的起点,彷佛山谷的门坎,自然的入口,实现了医院和自然环境这两种截然不同的环境之间的巧妙转换;折迭的运用,使建筑和地面融为一体,舒展简洁如折纸般轻巧而立,和不远的医院塔楼形成一种抗衡的态势。

位于苏格兰Kirkcaldy维多利亚医院的 Maggie's Centre Fife,是Zaha Hadid 在英国的第一个建筑。

这个耗资100万英镑的建筑也是 Maggie's Center 的第五座癌症中心,Maggie癌症中心是一个由Charles Jencks及其妻子Maggie Keswick创建的慈善机构,他们不仅向癌症患者提供免费服务,同时对其家人、朋友甚至护工也有相关的服务。

他们提供心理咨询,各种癌症相关书籍查阅,营养课程等,而且最重要的是为癌症病人提供了一个自由交流的平台,一个完全轻松自由的家庭式的治疗空间。

除了zaha hadid之外,还有许多著名的建筑师如Richard Murphy,Page & Park, Frank Gehry 和Richard Rogers都曾以其设计为Maggie癌症中心捐赠过。

Maggie's Fife第五癌症中心点击图片进入下一页>>Maggie's Fife第五癌症中心建筑和地形的关系Zaha Hadid通过在一块平板上的折迭形体解决了建筑与自然景观和位于其北部的医院停车场的关系的问题,这种折迭强调了来自医院各个方向的人群;覆盖着黑色闪光材料的耐候钢板的屋顶和墙也通过这种折迭形体结合为一体,并从不同的方向沿伸到外部环境中。

  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

CHATHAM SKIN AND CANCER CENTER, P.C.639A Stephenson Ave.Savannah, Georgia 31405(912) 354-7124OFFICE POLICIESThank you for choosing Chatham Skin & Cancer Center for your dermatological care. Dr. Gaughf graduated from the Medical College of Georgia, where she also completed her residency in Dermatology. She completed two years of Internal Medicine residency at Mercer University. Dr. Gaughf is Board Certified in Dermatology and is a member in good standing with the American Academy of Dermatology.The information below is designed to guide you through the rapidly changing world of medicine and managed care. We have developed many of the following policies in response to these changes in the medical delivery system, however we will always remain dedicated to preserving quality of care in medicine.We will require full payment at the time of service for all self pay patients. Co-pays and deductibles are due at the time of service for those insurance plans with which we are contracted. For those plans we are not contracted with, we will gladly file the insurance claim. Once payment has been received for the carrier a refund well be processed if one is due. Please contact your health insurance company for more information about out-of -network reimbursement. If you’re medical problem is of a non-emergency nature and you are unable to remit, we respectfully request that you reschedule.We accept cash, check, VISA, Master, and Discover Cards. Two party checks are not accepted.Office HoursNormal office hours are Monday -Thursday from 8:30am to 4:30pm and on Friday from 8:30am -12:30pm.The after hours phone number is for established patients that are experiencing an emergency and require immediate attention only.Office VisitsDue to high patient demand, problems and procedures including skin cancer surgery are limited to one or two per visit. In some cases you may have to schedule an appointment for a procedure.When the Doctor is awayFrom time to time the doctor will be away continuing her education so she can provide the best quality care. Another physician will be covering emergencies only. During these times we ask that you not request for prescription refills.Appointment Confirmation CallsAs a courtesy to our patients, appointment reminder calls will be made 2 days before a scheduled appointment, to the telephone number provided. If you do not wish to receive a reminder call, please notify the receptionist.Missed AppointmentsMissed appointments causes unnecessary expense and increased overhead for our office. If you can’t make your appointment please notify us 24 hours in advance. If you miss 3 consecutive appointments, then we will ask you to seek dermatological care elsewhere. All missed surgery appointments, not canceled 24 hours prior to the appointment time will be charged a $50.00 missed appointment fee.Emergency AppointmentsIf you have an emergency problem we will work you in to address that emergency problem only. We will be happy to schedule you a follow up appointment for further evaluation of your skin.MedicaidWe do not participate with Georgia Medicaid. If you have Georgia Medicaid you will be considered as a self-pay patient.Test Results/Refill RequestPlease allow 10-12 days for Pathology results. We will attempt to call every patient with these results. Certain results may require an office visit. If this is the case an appointment is necessary. Request for refills prior to one hour of closing will not be processed until the next business day. Your refill request may require an appointment because we don't authorize refills if you haven't seen the doctor within six months. If your request requires an office visit we will work you in as soon as possible. CollectionsAny account that is past due by 60 days will be charged a $3.00 rebilling fee. Any account that is past due 120 days will be assigned to a collection agency. Any patient requiring co1lections action will be discharged from this practice and must seek their care elsewhere.All return checks, will be assessed a $25 penalty and payment must be made within 10days.Patient ConfidentialityIt is our policy to adhere to all Health Insurance Portability & Accountability Act of 1996 (HIP AA) regulations, including Protected Health Information (PHI). It is not our policy to discuss your healthcare / diagnostic and/or accounting information with anyone other than yourself. If you would like an authorization to be kept on file releasing such information to someone other than yourself, please notify the receptionist.Minor ChildrenMinor children (under 18yrs of age) must be accompanied by a Legal Guardian. If the Legal Guardian can not accompany the minor, the person accompanying (name must be listed on letter) with the child must have a notarized letter from a legal guardian giving permission for Dr. Gaughf to treat the child when they cannot be present.CosmeticComplimentary cosmetic consultations are available with a member of our staff, however if you wish to schedule with Dr. Gaughf there is a $75.00 fee. Insurance companies generally do not pay for cosmetic services. If you desire to have a cosmetic procedure, then you will be expected to pay at time of service.InsuranceWe do accept assignment of benefits from insurance carriers. However many insurance company have restrictive payment rules. I understand that I am financially responsible for all charges, whether or not paid by said insurance company. Laboratory and Pathology ChargesWe use outside laboratories for blood work, x-rays, and examination of specimens. We do not bill for their professional services. You will receive a separate bill from these labs. If you have a question regarding the bill, please contact the laboratory directly.All patients are allowed direct access to a dermatologist without going through a referral by Georgia Open Access Law. If you have any questions or problems with your insurance carrier please contact our billing department at (912) 354-7124 EXT 103 ** BY SIGNING BELOW I ACKNOWLEDGE THAT I WILL ABIDE BY THE OFFICE POLICIES** Print Name:_______________________________________ Date: ___________________Signature: ________________________________________ Date: ___________________Medicare Patients OnlyI authorize any holder of medical or other information about me to be released to the Social Security Administration and Health Care Financing Administration or its intermediaries or carrier any information needed for this or related Medicare claims. I permit a copy of this authorization to be used in place of the original, and request payment of medical insurance benefits either to myself or the party who accepts assignments. Regulations pertaining to Medicare assignment of benefits apply. Signature: ________________________________________ Date: ___________________Medigap Patients OnlyI request that authorized MEDIGAP benefits be made on my behalf for any services furnished to me. I authorize any holder of medical information to release to the above MEDIGAP carrier any information needed to determine benefits.Signature: ________________________________________ Date: ___________________Collection AddendumI hereby agree that if my bill has to be turned over to a third party collection agency for non payment, there will be a collection fee added to my bill of 33%. This is pursuant to Georgia Statutory Law “O.C.G.A.-13-1-11”__________________________Responsible Party, GuarantorDermatology Medical HistoryPatient Date of Birth / / Today's Date: / / Reason for Today’s VisitAre you allergic to any medications? YES NO if yes, list below:1• 2.Have you ever had Dental anesthesia(Novocaine)? YES NO Any bad reaction? YES NOList all medications you are currently taking(including prescriptions, over-the-counter meds,vitamins,andherbals)1. 3. 5.2. 4. 6.Do you have now, or have you ever had diseases or conditions of (Please check YES or NO)Lungs: YES NO Other Systemic: YES NOBronchitis DiabetesEmphysema Excessive thirst/hungerAsthma AmputationChronic Cough ThyroidMorning Cough KidneyShortness of Breath DialysisWheezing BladderFrequency/BurningCardiovascular: Gastrointestinal:High Blood Pressure Stomach absorptive disorderChest Pain Nausea, vomiting, diarrheaHeart Attack when taking antibioticsHeart Murmur Yeast Infection whenIrregular Heartbeat taking antibioticsPhlebitis Arthritis/Joint DeformityInflammation of vein ArthralgiaBlood Clots Limited MotionPacemaker Artificial JointArtificial Heart Valve Convulsions, Epilepsy or SeizuresFaintingList any other disease or conditions:List surgical procedures you have had in last 6 monthsYES NOSKIN: Have you ever had skin cancer?Has anyone in your family had skin cancer?Do you have any history of any specific skin diseases?Do you have problems with healing?Do you develop keloids (scars) after surgery?Do you bleed easily?Do you develop skin rashes in reaction to Medications Food Environment BandagesTopical Neosporin OtherSOCIAL HISTORY: YES NODo you drink alcohol? If YES drinks per dayDo you use IV Drugs? If YES, what? How often?Do you smoke? If YES, how much?Have you had or have you been exposed to HIV(Aids)? YES NOWhat is your occupation? Hobbies?We recommend that a yearly full body skin exam is done. This includes the genital area as well. Many Melanomas or other skin cancers can be present without the patient knowing it’s there. If you desire a complete skin exam or a sun exposed skin areas only skin exam, please notify the receptionist during check out so that an appointment can be scheduled for a later time. Those at high risk are faired skinned, have moles, family history of melanoma, and much sun exposure or are immunosuppressed.Chatham Skin & Cancer Center, P.C.639A Stephenson Ave.Savannah, Georgia 31405(912) 354-7124Acct # ______________PATIENT DEMOGRAPHIC SHEETPlease PRINT the following informationAll information will be kept confidential Reg:________________Patient’s Name Marital StatusAge Date Of Birth SSNAddress City State ZipHome No. Work No. Cell No. ____________________E-mail Address__________________________________________________________Whom may we thank for referring you?_____________________________________Whom may we contact in cases of emergency?_______________________________ No. _______________________________ ***IF THE INSURED IS NOT THE PATIENT COMPLETE THIS SECTION ***By completing this section, I authorize Chatham Skin and Cancer Center, P.C. to disclose my healthcare, diagnostic, and account information to the person or persons listed below.Name of the Insured__________________________________________________Relationship to the Patient SSN Date Of BirthAddress City State ZipEmployer Work No.Home No.___________________ Test ResultsMay we leave test results on your answering machine? If no, you must call for test results.Authorization:I also authorize Chatham Skin and Cancer Center, P .C. to disclose my healthcare and diagnostic information to the person listed below.Name Relationship to PatientI authorize release of any information concerning me (or my child's) health care, advice and treatment to be provided to my referring physician and to others for the purpose of evaluating and administering claims for insurance benefits, this includes information related to psychiatric care, drug abuse and HIV / AIDS confidential information. I also authorize assignment of all medical/surgical benefits to Chatham Skin and Center, P.C. This assignment will remain in effect until revoke by me in writing.I also authorize any treatment such as skin biopsies or other necessary procedures as necessary for me (or my child’s) care. Signature Date*** A COPY OF YOUR IDENTIFICATION AND INSURANCE CARD WILL BE MADE***CHATHAM SKIN AND CANCER CENTER, P.C639A Stephenson Ave.Savannah, GA 31406(912) 354-7124PATIENT CONSENT FOR USE AND DISCLOSURE OF PROTECTED HEALTH INFORMATIONI hereby give my consent for Chatham Skin & Cancer Center, P.C. to use and disclose protected health information (PHI) about me to carry out treatment, payment and healthcare operations (TPO).Chatham Skin & Cancer Center, P.C Notice of Privacy Practices provides a more complete description of such usesand disclosures.I acknowledge receipt of Chatham Skin & Cancer Center, P.C. Notice of Privacy Practices.With this consent, Chatham Skin & Cancer Center, P.C. may call my home or other alternative location and leave a message on voice mail or in person in reference to any items that assist the practice in carrying out TPO, such as appointment reminders, insurance items and any calls pertaining to my clinical care, including but not limited to laboratory results.With this consent, Chatham Skin & Cancer Center, P.C. may mail and or send faxes to my home or other alternative location any items that assist the practice in carrying out TPO, such as appointment reminder cards and patient statements.With this consent, Chatham Skin & Cancer Center, P.C. may e-mail, to my home, other alternative location, any items that assist the practice in carrying out TPO, such as appointment reminder cards and patient statements. I have the right to request that Chatham Skin & Cancer Center, P.C. restrict how it uses or discloses my PHI to carry out TPO.However, the practice is not required to agree to my requested restrictions, but if it does, it is bound by this agreement.By signing this form, I am consenting to Chatham Skin & Cancer Center, P.C. use and disclosure of my PHI to carry out TPO.I may revoke my consent in writing except to the extent that the practice has already made disclosures in reliance upon my prior consent. If I do not sign this consent, or later revoke it, Chatham Skin & Cancer Center, P.C. may decline to provide treatment to me.*Chatham Skin & Cancer Center, P.C. reserves the right to revise its Notice of Privacy Practices at anytime. A revised Notice of Privacy Practices may be obtained by requesting a copy from the practice.This Consent was signed by:Signature of Patient or Legal GuardianPrint Name of Patient Date。

相关文档
最新文档